Delayed Graft Function
49
6
8
21
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
10.2%
5 terminated out of 49 trials
80.8%
-5.8% vs benchmark
27%
13 trials in Phase 3/4
29%
6 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (49)
The Impact of Intraoperative Diuretic Use on Delayed Graft Function Following Deceased Donor Renal Transplantation
Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation
Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function
The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients
Volatile Anesthetic Protection Of Renal Transplants 2
Better Evidence for Selecting Transplant Fluids
Study of the Correlation Between Donor CIRBP and Transplanted Kidney Function
Graft Acute Kidney Injury: Vitamin B3 to Facilitate Renal Recovery In the Early Life of a Transplant
Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys
Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations
Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation
Envarsus in Delayed Graft Function (E-DGF)
Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation
Deceased Organ Donor Interventions to Protect Kidney Graft Function
Tacrolimus to Sirolimus Conversion for Delayed Graft Function
Belatacept for Renal Transplant Recipients With Delayed Graft Function
Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney